Canine osteosarcoma treatment
Canine osteosarcoma treatment
A novel therapeutic approach for canine osteosarcoma treatment consists of sparing the limb in affected dogs. Instead of amputation, the affected bone is resected and an allograft from a cadavar is used to replace the neoplastic bone; novel biomaterials are also currently being investigated for this purpose. This canine osteosarcoma treatment means that dogs are also treated with intravenous cisplatin, carboplatin, or doxorubicin and, in general, have almost limb function. The main complication is the development of osteomyelitis in the allograft; if that occurs, the limb frequently needs to be amputated. Survival times in animals undergoing this dog osteosarcoma treatment are comparable to those in dogs that undergo amputation plus chemotherapy, the added benefit to the owners of having a four-legged pet.
If owners are reluctant to allow the clinician to amputate te limb, local radiotherapy plus cisplatin, carboplatin, or doxorubicin may be of some benefit. However, in our limited experience, most dogs are eventually euthanized within 3 to 4 months of the initial diagnosis because of the development of pathologic fractures (i.e., after radiotherapy, the tumor is not as painful, therefore the dog regains normal use of the limb and fractures the area), osteomyelitis, or metastasic lesions.
A more conventional canine osteosarcoma treatment is chemotherapy. Chemotherapy apparently modifies the biologic behavior of the tumor, resulting in a higher prevalence of bone metastases and a lower prevalence of pulmonary metastases. Moreover, the doubling time (growth rate) of metastatic lesions appears to be longer than in untreated dogs. Therefore, surgical removal of the metastatic nodules (metastasectomy) followed by additional cisplatin or carboplatin therapy may be recommended for a dog that has been treated with chemotherapy after amputation of the limb and in which one to three pulmonary metastatic lesions are detected.
We would love to hear your pet's story. Please add a comment.
A novel therapeutic approach for canine osteosarcoma treatment consists of sparing the limb in affected dogs. Instead of amputation, the affected bone is resected and an allograft from a cadavar is used to replace the neoplastic bone; novel biomaterials are also currently being investigated for this purpose. This canine osteosarcoma treatment means that dogs are also treated with intravenous cisplatin, carboplatin, or doxorubicin and, in general, have almost limb function. The main complication is the development of osteomyelitis in the allograft; if that occurs, the limb frequently needs to be amputated. Survival times in animals undergoing this dog osteosarcoma treatment are comparable to those in dogs that undergo amputation plus chemotherapy, the added benefit to the owners of having a four-legged pet.
If owners are reluctant to allow the clinician to amputate te limb, local radiotherapy plus cisplatin, carboplatin, or doxorubicin may be of some benefit. However, in our limited experience, most dogs are eventually euthanized within 3 to 4 months of the initial diagnosis because of the development of pathologic fractures (i.e., after radiotherapy, the tumor is not as painful, therefore the dog regains normal use of the limb and fractures the area), osteomyelitis, or metastasic lesions.
A more conventional canine osteosarcoma treatment is chemotherapy. Chemotherapy apparently modifies the biologic behavior of the tumor, resulting in a higher prevalence of bone metastases and a lower prevalence of pulmonary metastases. Moreover, the doubling time (growth rate) of metastatic lesions appears to be longer than in untreated dogs. Therefore, surgical removal of the metastatic nodules (metastasectomy) followed by additional cisplatin or carboplatin therapy may be recommended for a dog that has been treated with chemotherapy after amputation of the limb and in which one to three pulmonary metastatic lesions are detected.
We would love to hear your pet's story. Please add a comment.
MORE VETERINARY ARTICLES
-
The strength and regularity of the peripheral arterial pressure waves and the pulse rate are assessed by palpation of the femoral or other p...
-
System venous and right heart filling pressures are reflected at the jugular veins in dogs and cats . These veins should not be distended wh...
-
Pulmonary contusion in dogs and cats is caused by blunt trauma and is a common finding in animals that have been hit by cars. Hemorrhage in...
-
Renal enlargement is usually detected by physical examination or by abdominal radiography or by ultrasonography . A quick rule of thumb is ...
-
Mucous membrane color and capillary refill time (CRT) are used to estimate the adequacy of peripheral perfusion. Normally the oral membranes...
-
Thoracic auscultation in dogs and cats is used to identify normal heart sounds, determine the presence or absence of abnormal sounds, asses...
-
Signs and symptoms of syncope in dogs and cats . Cardiac output often becomes inadequate in animals with heart disease or heart failure , e...
-
Canine Leukemia | Leukemia in Dogs In dog leukemias constitute fewer than 10% of all hemolymphatic neoplasms and are therefore consider...
-
Dog Names Give a name to your dog The name you will choose for your dog is tied to your personality. It reflects the relationship you w...
-
The same general mechanisms that cause edema elsewhere in the body cause edema in the pulmonary parenchyma. Major mechanisms are decreased ...
